Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Limited utility of Epstein–Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients

Journal of Clinical Virology(2024)10.1016/j.jcv.2024.105758Source: DataRank Database

Limited utility of Epstein–Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients is a research paper published in Journal of Clinical Virology (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.52)OA: greenTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Patrick Tam ORCID,Yeh-Chung Chang ORCID,Jennifer H. Saullo,Arthur W. Baker ORCID,Eileen K Maziarz ORCID

Live enrichment

PubMed:39700902 PMC:PMC11975427 OpenAlex:https://openalex.org/W4405374060

National Institutes of Health

Grant: K08-AI163462

NIAID NIH HHS

Grant: K08 AI163462

National Institute of Allergy and Infectious Diseases

FWCI

0.52

Citation Percentile

0.7%

Citation Trend

2025

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11975427/

publisherhttps://api.elsevier.com/content/article/PII:S1386653224001203?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1386653224001203?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jcv.2024.105758

Fields of Study

Viral-associated cancers and disordersHead and Neck Cancer StudiesCytomegalovirus and herpesvirus researchHumansLymphoproliferative DisordersLung TransplantationEpstein-Barr Virus InfectionsRetrospective StudiesMaleFemaleMiddle AgedAdultHerpesvirus 4, HumanTransplant RecipientsViral LoadDNA, ViralAgedPredictive Value of TestsYoung Adult

MeSH Terms

AdultAgedDNA, ViralHerpesvirus 4, HumanFemaleHumansLymphoproliferative DisordersMaleMiddle AgedPredictive Value of TestsRetrospective StudiesLung TransplantationViral LoadEpstein-Barr Virus InfectionsYoung AdultTransplant Recipients

Keywords

Lymphoproliferative disordersEpstein–Barr virusPost-transplant lymphoproliferative disorderImmunologyMedicineLungVirologyVirusEpstein–Barr virus infectionLymphomaInternal medicineDiagnostic StewardshipLung Transplant Recipients Viral Pcr Testing

Sustainable Development Goals

SDG 0: Good health and well-being